Differential Diagnosis for Ocular Myasthenia Gravis
The differential diagnosis for ocular myasthenia gravis includes any pupil-sparing ocular motility disorder, with the most critical distinctions being third nerve palsy, thyroid eye disease, chronic progressive external ophthalmoplegia, Lambert-Eaton syndrome, botulism, brainstem lesions, and orbital pathology. 1, 2
Key Distinguishing Feature: Pupil-Sparing Pattern
Pupils are characteristically not affected in myasthenia gravis, which serves as the most important distinguishing feature from other causes of ophthalmoplegia and ptosis. 2 If pupils are abnormal, immediately prioritize evaluation for third nerve palsy, Horner syndrome, or other neurologic causes over myasthenia gravis. 2 This pupil-sparing pattern occurs because myasthenia affects nicotinic receptors at the neuromuscular junction of voluntary skeletal muscles, not the autonomic nervous system responsible for pupillary function. 2
Primary Differential Diagnoses
Third Nerve Palsy
- Most critical distinction: Third nerve palsy can present with ptosis and ophthalmoplegia but typically involves pupillary abnormalities (though pupil-sparing variants exist). 1, 2
- Requires immediate neuroimaging and vascular workup given risk of aneurysm or ischemia. 1
- Unlike myasthenia, weakness pattern follows anatomic distribution of third nerve rather than variable, fatigable pattern. 3
Thyroid Eye Disease (TED)
- Second most common mimic: TED causes restrictive myopathy with mechanical limitation rather than neuromuscular junction dysfunction. 1
- Key distinguishing features include proptosis (measured by exophthalmometry), eyelid retraction, and fixation duress (brow elevation with attempted upgaze). 1
- Forced duction testing confirms mechanical restriction in TED versus fatigable weakness in myasthenia. 1
- Inferior rectus most commonly affected, followed by medial rectus, causing hypotropia with esotropia. 1
- Orbital imaging shows tendon-sparing muscle enlargement in TED. 1
- Critical pitfall: Myasthenia incidence is increased in TED patients, so assess for coexistence if clinical examination suggests both. 1
Chronic Progressive External Ophthalmoplegia (CPEO)
- Presents with slowly progressive, symmetric ophthalmoplegia and ptosis without fluctuation or fatigability. 3
- Lacks the variability and fatigue pattern characteristic of myasthenia. 4, 3
- Mitochondrial disorders should be considered with family history or systemic features. 3
Lambert-Eaton Myasthenic Syndrome (LEMS)
- Autoimmune disorder affecting presynaptic calcium channels rather than postsynaptic acetylcholine receptors. 4, 3
- Weakness typically improves with repeated muscle contraction (opposite of myasthenia). 3
- More commonly affects proximal limb muscles; ocular involvement less prominent than in myasthenia. 4
- Associated with small cell lung cancer in 50-60% of cases. 3
Botulism
- Acute onset of descending paralysis with pupillary involvement (dilated, poorly reactive pupils). 4, 3
- History of contaminated food, wound infection, or infant exposure. 3
- Autonomic dysfunction prominent (unlike myasthenia's pupil-sparing pattern). 2, 3
Brainstem Lesions
- Stroke, demyelination, or tumor affecting midbrain/pons can mimic ocular myasthenia. 3
- Associated with other brainstem signs (sensory changes, ataxia, altered consciousness). 3
- Neuroimaging (MRI brain with contrast) essential to exclude. 3
Orbital Pathology
- Orbital tumors, inflammation (orbital myositis), or infiltrative processes can restrict eye movements. 3
- Orbital imaging distinguishes these from myasthenia. 1, 3
- Pain more common with orbital inflammation than myasthenia. 3
Secondary Considerations
Congenital Myasthenic Syndromes
- Not immune-mediated; present in childhood with lifelong symptoms. 1
- Genetic testing confirms diagnosis. 1
Oculopharyngeal Muscular Dystrophy
- Progressive ptosis and dysphagia without fluctuation. 3
- Positive family history in autosomal dominant inheritance pattern. 3
Systemic Conditions Causing Fluctuating Symptoms
- Encephalopathy, sepsis, or metabolic derangements can produce fluctuating ptosis or eye movements. 3
- However, myasthenia is almost never found when weakness or fatigue symptoms lack objective neurological correlate. 3
Diagnostic Approach to Differentiate
Clinical Examination Priorities
- Assess pupillary function first as part of initial examination in patients with ptosis and ophthalmoplegia. 2
- Document variability and fatigability: symptoms worsen with sustained upgaze or at end of day. 1, 4
- Perform ice pack test: apply ice over closed eyes for 2 minutes; highly specific for myasthenia if symptoms improve. 2, 5
- Forced duction testing distinguishes mechanical restriction (TED, orbital pathology) from neuromuscular weakness. 1
Laboratory and Electrodiagnostic Testing
- Anti-AChR antibodies present in only 40-77% of ocular myasthenia (versus nearly all generalized cases). 1, 5
- Single-fiber EMG has >90% sensitivity for ocular myasthenia; repetitive nerve stimulation only 33% sensitive. 5
- Anti-MuSK antibodies should be tested when AChR antibodies negative. 5
Imaging Studies
- Orbital CT/MRI differentiates TED (tendon-sparing muscle enlargement) from myasthenia. 1
- Brain MRI with contrast excludes brainstem lesions. 3
- Chest CT with contrast mandatory after myasthenia diagnosis to evaluate for thymoma. 5
Critical caveat: Approximately 50-80% of patients presenting with isolated ocular symptoms will develop generalized myasthenia within a few years, making accurate diagnosis essential for preventing life-threatening respiratory failure. 1, 5